Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 29,078 | 25,967 | 24,234 | 22,504 | 19,221 |
| Cost of Goods | 2,947 | 2,807 | 3,233 | 2,412 | 2,236 |
| Gross Profit | 26,131 | 23,160 | 21,001 | 20,092 | 16,985 |
| Operating Expenses | 67,556 | 163,854 | 62,503 | 64,457 | 63,825 |
| Operating Income | -40,478 | -139,887 | -41,269 | -43,953 | -46,604 |
| Interest Expense | 4,603 | 4,755 | 4,379 | 3,149 | 3,303 |
| Other Income | 13,299 | 3,570 | 4,211 | 3,307 | 3,204 |
| Pre-tax Income | -31,782 | -141,072 | -41,437 | -43,795 | -46,703 |
| Income Tax | 479 | 300 | 196 | 368 | N/A |
| Net Income Continuous | -32,261 | -141,372 | -41,633 | -44,163 | -46,703 |
| Net Income | $-32,261 | $-141,372 | $-41,633 | $-44,163 | $-46,703 |
| EPS Basic Total Ops | -0.55 | -2.35 | -0.70 | -0.76 | -0.82 |
| EPS Basic Continuous Ops | -0.53 | -2.35 | -0.70 | -0.76 | -0.82 |
| EPS Diluted Total Ops | -0.55 | -2.35 | -0.70 | -0.76 | -0.82 |
| EPS Diluted Continuous Ops | -0.53 | -2.35 | -0.70 | -0.76 | -0.82 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -2.35 | -0.70 | N/A | N/A |
| EBITDA(a) | $-40,088 | $-139,482 | $-40,852 | $-43,511 | $-49,223 |